.Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01X_OtherAntineoplasticAgents.L01XX77_Adagrasib.Adagrasib

Information

name:Adagrasib
ATC code:L01XX77
route:oral
n-compartments2

Adagrasib is an orally active, irreversible KRAS G12C inhibitor used in the treatment of non-small cell lung cancer (NSCLC) with KRAS G12C mutation. It is approved for medical use for this indication.

Pharmacokinetics

Population pharmacokinetic parameters in adult patients with advanced solid tumors (predominantly NSCLC), both sexes, median age ~65 years.

References

    Revisions

    Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos